专利检索 ap:("ONYX PHARMACEUTICALS, INC.") AND inv:"Christopher J. Kirk" 第 1 页

1.

发明授权
Peptide epoxyketone proteasome inhibitors in combination with PIM kinase inhibitors for treatment of cancers 有权

公开(公告)号：US12076363B2

公开(公告)日：2024-09-03

申请号：US17482699

申请日：2021-09-23

申请人： ONYX PHARMACEUTICALS, INC.

发明人： Shirin Kapur , Alana Lerner , Christopher J. Kirk , Eric Lowe , Tracey Lin

IPC分类号： A61K38/07 , A61K31/426 , A61K31/427 , A61K31/454 , A61K31/4545 , A61K31/4745 , A61K31/5025 , A61K31/506 , A61K31/5377 , A61K38/04 , A61K38/06 , A61K38/08 , A61K45/06 , C07K5/083 , C07K5/107

CPC分类号： A61K38/07 , A61K31/426 , A61K31/427 , A61K31/454 , A61K31/4545 , A61K31/4745 , A61K31/5025 , A61K31/506 , A61K31/5377 , A61K38/04 , A61K38/06 , A61K38/08 , A61K45/06 , C07K5/081 , C07K5/1016 , A61K38/06 , A61K2300/00 , A61K38/07 , A61K2300/00 , A61K31/4745 , A61K2300/00 , A61K31/5025 , A61K2300/00 , A61K31/426 , A61K2300/00 , A61K31/5377 , A61K2300/00 , A61K31/506 , A61K2300/00 , A61K31/4545 , A61K2300/00 , A61K31/427 , A61K2300/00 , A61K31/454 , A61K2300/00

摘要： This disclosure provides methods of treating a cancer in a patient using a peptide epoxyketone proteasome inhibitor in combination with a PIM kinase inhibitor.

2.

发明申请
PEPTIDE EPOXYKETONE PROTEASOME INHIBITORS IN COMBINATION WITH PIM KINASE INHIBITORS FOR TREATMENT OF CANCERS 有权

公开(公告)号：US20220265758A1

公开(公告)日：2022-08-25

申请号：US17482699

申请日：2021-09-23

申请人： ONYX PHARMACEUTICALS, INC.

发明人： Shirin Kapur , Alana Lerner , Christopher J. Kirk , Eric Lowe , Tracey Lin

IPC分类号： A61K38/07 , A61K38/04 , A61K38/08 , A61K31/426 , A61K31/4745 , A61K31/506 , A61K38/06 , A61K31/427 , A61K31/454 , A61K31/4545 , A61K31/5025 , A61K31/5377 , A61K45/06 , C07K5/083 , C07K5/107

摘要： This disclosure provides methods of treating a cancer in a patient using a peptide epoxyketone proteasome inhibitor in combination with a PIM kinase inhibitor.